Completed
Intranasal Submucosal Bevacizumab for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
NCT01314274
- Conditions
- Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +20 more
- Locations
-
- Universitätsklinik für HNO, Medizinische Univeristät Wien Vienna, Austria